Erbitux Prices, Coupons, Copay Cards & Patient Assistance
Erbitux (cetuximab) is a member of the EGFR inhibitors drug class and is commonly used for Colorectal Cancer, Head and Neck Cancer, and Squamous Cell Carcinoma.
Erbitux prices
Intravenous Solution
2 mg/mL Erbitux intravenous solution from $876.97 for 50 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 50 milliliters | $17.54 | $876.97 |
| 100 milliliters | $17.44 | $1,743.92 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Erbitux Coupons, Copay Cards and Rebates
Erbitux offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Erbitux Savings Card
Eligible commercially insured patients may pay as little as $25 per monthly dose up to a monthly savings cap; maximum savings of $25,000 per 12-month enrollment period; card expires at the end of each calendar year; for additional information contact the program at 866-472-8663.
- Applies to:
- Erbitux
- Number of uses:
- 12 times within calendar year
- Expires
- December 31, 2025
Form more information phone: 866-472-8663 or Visit website
Patient Assistance & Copay Programs for Erbitux
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Erbitux (cetuximab) Injection; IV
More information please phone: 866-316-7263 Visit website
Provider: Lilly Cares Foundation Patient Assistance Program
Eligibility requirements:- Contact program for details.
- Varies
- Not specified
- The patient must also be residing in the US.
- Please visit www.LillyCares.com or call (800) 545-6962 for more information. Additional products may be available. Please contact the program for a complete product listing. Lilly donates products to the Lilly Cares Foundation Patient Assistance Program.
- Erbitux (cetuximab) Injection; IV
More information please phone: 800-545-6962 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Libtayo
Libtayo (cemiplimab-rwlc) is used to treat metastatic cutaneous squamous cell carcinoma, basal cell ...
Blenoxane
Blenoxane is used for hodgkin's lymphoma, non-hodgkin's lymphoma, squamous cell carcinoma ...
Unloxcyt
Unloxcyt (cosibelimab-ipdl) is an anti-PD-1 treatment for metastatic or advanced cutaneous squamous ...
Cemiplimab
Cemiplimab is used for basal cell carcinoma, non small cell lung cancer, squamous cell carcinoma
Bleomycin
Bleomycin is used for hodgkin's lymphoma, malignant pleural effusion, non-hodgkin's lymphoma ...
Pembrolizumab
Pembrolizumab (Keytruda) is a monoclonal antibody cancer medicine used to treat
More about Erbitux (cetuximab)
- Check interactions
- Compare alternatives
- Reviews (9)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: EGFR inhibitors
- Breastfeeding
- En español